<DOC>
	<DOCNO>NCT01659411</DOCNO>
	<brief_summary>Multi-center , observational , U.S.-based longitudinal program . Data collect prospectively 3 year . Individual physician feedback provide data collect purpose improve management patient - quality enhancement research initiative ( QuERI ) process adult patient enrol history repair Congenital Heart Disease ( CHD ) .</brief_summary>
	<brief_title>Adult Congenital Heart Disease Registry ( QuERI )</brief_title>
	<detailed_description>Approximately 800 male female adult patient history repair CHD recruit approximately 100 cardiology practice follow every twelve month period three year . Consecutive patient practice meeting inclusion exclusion criterion consider study . Two group subject enrol base identical exclusion criterion inclusion criterion , exception inclusion criterion # 3 : cohort 1- demonstrate historic high risk criterion cohort 2 - demonstrating current high risk criterion .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<criteria>Cohort 1 ( historic high risk ) 1 . Male female adult ( ≥ 18 year age ) 2 . Patients documented history ( least one year ) isolate , repair congenital heart defect ASD , VSD , PDA , AVC ( AVSD ) 3 . History large defect prior closure evidence one following : Size : ASD &gt; 2 cm ; VSD &gt; 1 cm ; PDA &gt; 0.6 cm Shunt 2:1 great Preoperative PH ( PAS &gt; 40 mmHg ) document shunt related heart failure ( radiographic evidence ) Preoperative atrial fibrillation flutter 4 . High risk feature ( one follow ) : Age &gt; 40 year Later surgical repair : . ≥ 2 year age PDA VSD ii . ≥ 1 year age AVC iii . ≥ 10 year age ASD Sinus venosus defect Primum defect WHO functional class &gt; 1 Atrial fibrillation flutter 5 . Echocardiographic evidence high risk feature . Any one following : Degree TR mild great Right ventricular ( RV ) systolic dysfunction Evidence RV dilatation : Any one following : . Evidence RV dilation general , qualitative assessment ii . RV end diastolic diameter &gt; 3.2 cm apical 4 chamber view tip tricuspid valve iii . RV LV ratio enddiastole &gt; 0.6 ( RV LV end diastolic dimension measure apical 4 chamber view , 1 cm apical respective valve annulus ) Any abnormality motion interventricular septum 6 . Ability desire execute consent follow Cohort 2 ( current high risk ) 1 . Male female adult ( ≥ 18 year age ) 2 . Patients documented history ( least one year ) isolate , repair congenital heart defect ASD , VSD , PDA , AVC ( AVSD ) 3 . Current ( within last 12 month ) evidence 1 7 follow criterion : Desaturation exercise ( 92 % less ) 6 MWD &lt; 380 PFT demonstrate DLC &lt; 70 % predict &amp; FEV1 &gt; 70 % predict ECG demonstrate ) RAD ii ) RVH RAE Physical finding edema accompany elevated JVP +HJR CXR evidence enlarge main and/or hilar pulmonary arterial shadow association right ventricular enlargement Elevated biomarks ( BNP NTproBNP upper limit normal ) 4 . High risk feature ( one following : ) Age &gt; 40 year Later surgical repair : . ≥ 2 year age PDA VSD ii . ≥ 1 year age AVC iii . ≥ 10 year age ASD Sinus venosus defect Primum defect WHO functional class &gt; 1 Atrial fibrillation flutter 5 . Echocardiographic evidence high risk feature . Any one following : Degree TR mild great Right ventricular ( RV ) systolic dysfunction Evidence RV dilatation : Any one following : . Evidence RV dilation general , qualitative assessment ii . RV end diastolic diameter &gt; 3.2 cm apical 4 chamber view tip tricuspid valve iii . RV LV ratio enddiastole &gt; 0.6 ( RV LV end diastolic dimension measure apical 4 chamber view , 1 cm apical respective valve annulus ) Any abnormality motion interventricular septum 6 . Ability desire execute consent follow 1 . Poor mental function , drug substance ( e.g. , alcohol ) abuse , unstable psychiatric illness , , opinion investigator , may interfere optimal participation study 2 . Diagnosis PAH ( define RHC demonstrate mPAP ≥ 25 mm Hg PCWP ≤ 15 PVR &gt; 3 WU PVR ( index ) &gt; 4 WU treatment PAH specific therapy ) surgical repair prior visit 1 3 . Prior inclusion registry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Congenital Heart Disease</keyword>
	<keyword>Pulmonary Arterial Hypertension</keyword>
</DOC>